Il y a eu 50 transactions d'initiés récentes enregistrées pour Milestone Pharmaceuticals Inc. (MIST), dont 35 achats et 12 ventes. Le total des achats d'initiés s'élève à $5.4M et le total des ventes d'initiés à $958.19K.
Les initiés notables ayant une activité récente comprennent Sandoval David I., Oliveto Joseph, Muller Lorenz. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — MIST
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-17 |
Sandoval David I. |
Gc & Chief Compliance Officer |
Inconnu |
400,000 |
$1.96 |
$784K |
- |
| 2026-02-02 |
Oliveto Joseph |
President and CEO |
Attribution de RSU |
453,000 |
- |
- |
453,000 |
| 2026-02-02 |
Muller Lorenz |
Chief Commercial Officer |
Attribution de RSU |
136,000 |
- |
- |
136,000 |
| 2026-02-02 |
Hasija Amit |
CFO & EVP of Corp. Development |
Attribution de RSU |
136,000 |
- |
- |
136,000 |
| 2026-02-02 |
Bharucha David |
Chief Medical Officer |
Attribution de RSU |
136,000 |
- |
- |
136,000 |
| 2026-02-02 |
Nelson Jeffrey Edward |
Chief Operating Officer |
Attribution de RSU |
136,000 |
- |
- |
136,000 |
| 2026-02-02 |
Oliveto Joseph |
President and CEO |
Attribution de RSU |
679,000 |
$1.96 |
$1.33M |
679,000 |
| 2026-02-02 |
Muller Lorenz |
Chief Commercial Officer |
Attribution de RSU |
204,000 |
$1.96 |
$399.84K |
204,000 |
| 2026-02-02 |
Hasija Amit |
CFO & EVP of Corp. Development |
Attribution de RSU |
204,000 |
$1.96 |
$399.84K |
204,000 |
| 2026-02-02 |
Bharucha David |
Chief Medical Officer |
Attribution de RSU |
204,000 |
$1.96 |
$399.84K |
204,000 |
| 2026-02-02 |
Nelson Jeffrey Edward |
Chief Operating Officer |
Attribution de RSU |
204,000 |
$1.96 |
$399.84K |
204,000 |
| 2026-01-26 |
Oliveto Joseph |
President and CEO |
Exercice d'Options (Vente) |
66,600 |
- |
- |
199,800 |
| 2026-01-26 |
Muller Lorenz |
Chief Commercial Officer |
Exercice d'Options (Vente) |
20,100 |
- |
- |
60,300 |
| 2026-01-26 |
Hasija Amit |
CFO & EVP of Corp. Development |
Exercice d'Options (Vente) |
20,100 |
- |
- |
60,300 |
| 2026-01-26 |
Bharucha David |
Chief Medical Officer |
Exercice d'Options (Vente) |
20,100 |
- |
- |
60,300 |
| 2026-01-26 |
Nelson Jeffrey Edward |
Chief Operating Officer |
Vente Informative |
12,245 |
$1.93 |
$23.63K |
49,848 |
| 2026-01-08 |
Oliveto Joseph |
President and CEO |
Vente Informative |
43,000 |
$2.25 |
$96.75K |
303,721 |
| 2026-01-07 |
Oliveto Joseph |
President and CEO |
Vente Informative |
500 |
$2.25 |
$1.13K |
346,721 |
| 2025-12-15 |
Oliveto Joseph |
President and CEO |
Vente Informative |
133,054 |
$2.32 |
$308.69K |
450,667 |
| 2025-12-15 |
Muller Lorenz |
Chief Commercial Officer |
Vente Informative |
53,566 |
$2.32 |
$124.27K |
196,486 |
| 2025-12-15 |
Hasija Amit |
CFO & EVP of Corp. Development |
Vente Informative |
58,007 |
$2.32 |
$134.58K |
91,993 |
| 2025-12-15 |
Bharucha David |
Chief Medical Officer |
Vente Informative |
58,007 |
$2.32 |
$134.58K |
105,326 |
| 2025-12-15 |
Nelson Jeffrey Edward |
Chief Operating Officer |
Vente Informative |
58,007 |
$2.32 |
$134.58K |
41,993 |
| 2025-12-12 |
Oliveto Joseph |
President and CEO |
Attribution de RSU |
280,000 |
$1.74 |
$487.2K |
280,000 |
| 2025-12-12 |
Muller Lorenz |
Chief Commercial Officer |
Attribution de RSU |
100,000 |
$1.74 |
$174K |
100,000 |
| 2025-12-12 |
Hasija Amit |
CFO & EVP of Corp. Development |
Attribution de RSU |
100,000 |
$1.74 |
$174K |
100,000 |
| 2025-12-12 |
Bharucha David |
Chief Medical Officer |
Attribution de RSU |
100,000 |
$1.74 |
$174K |
100,000 |
| 2025-12-12 |
Nelson Jeffrey Edward |
Chief Operating Officer |
Attribution de RSU |
100,000 |
$1.74 |
$174K |
100,000 |
| 2025-12-09 |
Muller Lorenz |
Chief Commercial Officer |
Don (Donné) |
25,000 |
- |
- |
150,052 |
| 2025-07-11 |
Papa Joseph C |
Director |
Attribution de RSU |
100,000 |
$1.88 |
$187.5K |
100,000 |
| 2025-07-11 |
Oliveto Joseph |
President and CEO |
Attribution de RSU |
66,666 |
$1.88 |
$125K |
66,666 |
| 2025-07-11 |
Wills Robert James |
Director |
Attribution de RSU |
50,000 |
$1.50 |
$75K |
50,000 |
| 2025-07-11 |
Muller Lorenz |
Chief Commercial Officer |
Attribution de RSU |
66,666 |
$1.50 |
$100K |
66,666 |
| 2025-07-11 |
Liebert Debra K. |
Director |
Attribution de RSU |
16,666 |
$1.50 |
$25K |
16,793 |
| 2025-07-11 |
Hasija Amit |
CFO & EVP of Corp. Development |
Attribution de RSU |
50,000 |
$1.50 |
$75K |
50,000 |
| 2025-07-11 |
Bharucha David |
Chief Medical Officer |
Attribution de RSU |
53,333 |
$1.88 |
$100K |
53,333 |
| 2025-06-10 |
Papa Joseph C |
Director |
Attribution de RSU |
40,000 |
$1.75 |
$70K |
40,000 |
| 2025-06-10 |
Giles Lisa M. |
Director |
Attribution de RSU |
40,000 |
$1.75 |
$70K |
40,000 |
| 2025-06-10 |
Tomsicek Michael John |
Director |
Attribution de RSU |
40,000 |
$1.75 |
$70K |
40,000 |
| 2025-06-10 |
Fischer Seth H. Z. |
Director |
Attribution de RSU |
40,000 |
$1.75 |
$70K |
40,000 |
| 2025-06-10 |
Saik Andrew |
Director |
Attribution de RSU |
40,000 |
$1.75 |
$70K |
40,000 |
| 2025-06-10 |
Wills Robert James |
Director |
Attribution de RSU |
40,000 |
$1.75 |
$70K |
40,000 |
| 2025-06-10 |
Duty Stuart |
Director |
Attribution de RSU |
40,000 |
$1.75 |
$70K |
40,000 |
| 2025-01-27 |
Oliveto Joseph |
President and CEO |
Attribution de RSU |
266,400 |
- |
- |
266,400 |
| 2025-01-27 |
Muller Lorenz |
Chief Commercial Officer |
Attribution de RSU |
80,400 |
- |
- |
80,400 |
| 2025-01-27 |
Hasija Amit |
CFO & EVP of Corp. Development |
Attribution de RSU |
80,400 |
- |
- |
80,400 |
| 2025-01-27 |
Bharucha David |
Chief Medical Officer |
Attribution de RSU |
80,400 |
- |
- |
80,400 |
| 2025-01-27 |
Nelson Jeffrey Edward |
Chief Operating Officer |
Attribution de RSU |
80,400 |
- |
- |
80,400 |
| 2024-09-03 |
Papa Joseph C |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-09-03 |
Papa Joseph C |
Director |
Attribution de RSU |
80,000 |
$1.39 |
$111.2K |
80,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi